Protara Therapeutics Stock Investor Sentiment

TARA Stock  USD 3.50  0.02  0.57%   
About 56% of Protara Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Protara Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Protara Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Protara Therapeutics stock news signals to limit their universe of possible portfolio assets.
  
23 hours ago at gurufocus.com         
Protara Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
Gurufocus Stories at Macroaxis
over a week ago at gurufocus.com         
RA CAPITAL MANAGEMENT, L.P. Increases Stake in Protara Therapeutics Inc.
Gurufocus Stories at Macroaxis
over a week ago at gurufocus.com         
JANUS HENDERSON GROUP PLC Acquires Significant Stake in Protara Therapeutics Inc
Gurufocus Stories at Macroaxis
over two weeks ago at news.google.com         
Certain Common Warrants of Protara Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 9...
Google News at Macroaxis
over two weeks ago at gurufocus.com         
Protara Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Gurufocus Stories at Macroaxis
over three weeks ago at thelincolnianonline.com         
Protara Therapeutics, Inc. Short Interest Update
news
over three weeks ago at businesswire.com         
TARA Mind Launches Free Provider Training to Advance Clinicians Expertise in Life-Saving Mental Heal...
businesswire News
over a month ago at www.macroaxis.com         
Acquisition by Levy Richard S of 10000 shares of Protara Therapeutics at 2.85 subject to Rule 16b-3
Macroaxis News
over a month ago at www.macroaxis.com         
Acquisition by Fabbio Patrick of 23500 shares of Protara Therapeutics subject to Rule 16b-3
Macroaxis News
over a month ago at businesswire.com         
Mental Health Savings Calculator Powered by TARA Mind Launches to Help Employers Combat Corporate Am...
businesswire News
over a month ago at www.macroaxis.com         
Disposition of 6554 shares by Zummo Jacqueline of Protara Therapeutics at 4.76 subject to Rule 16b-3
Macroaxis News
over a month ago at gurufocus.com         
Protara Highlights Recent Updates and Anticipated 2025 Milestones
Gurufocus Stories at Macroaxis
over a month ago at gurufocus.com         
Protara Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Gurufocus Stories at Macroaxis
over a month ago at www.macroaxis.com         
Disposition of 4 shares by Hannah Fry of Protara Therapeutics at 6.14 subject to Rule 16b-3
Macroaxis News
over two months ago at thelincolnianonline.com         
Protara Therapeutics, Inc. Short Interest Up 79.1 percent in December
news
Far too much social signal, news, headlines, and media speculation about Protara Therapeutics that are available to investors today. That information is available publicly through Protara media outlets and privately through word of mouth or via Protara internal channels. However, regardless of the origin, that massive amount of Protara data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Protara Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Protara Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Protara Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Protara Therapeutics alpha.

Protara Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Protara Stock analysis

When running Protara Therapeutics' price analysis, check to measure Protara Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protara Therapeutics is operating at the current time. Most of Protara Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protara Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protara Therapeutics' price. Additionally, you may evaluate how the addition of Protara Therapeutics to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like